Actively Recruiting
Clinical Evaluation of Low Contrast Defocus Curves, Low Light Photic Phenomena, and Dysphotopsia Profiles in Pseudophakic Patients
Led by Dr. Daniel H. Chang, MD · Updated on 2026-04-06
120
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
D
Dr. Daniel H. Chang, MD
Lead Sponsor
J
Johnson & Johnson Surgical Vision, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying how different types of intraocular lenses (IOLs) affect visual performance in low light and low contrast conditions after cataract surgery. The study compares three IOL models to understand their impact on vision, nighttime side effects, and patient satisfaction. The goal is to better correlate objective measures with patient-reported visual experiences, including dysphotopsia, which are visual disturbances like glare or halos. Participants will be grouped based on the type of Tecnis intraocular lens they have received: Monofocals, Symfony Optiblue, or Odyssey models. They will complete questionnaires about their vision and undergo a variety of visual tests using specialized devices. These tests include measuring visual acuity, contrast sensitivity, pupil size, defocus curves, and photic phenomena under different lighting and color conditions. The study also includes slit-lamp exams and intraocular pressure measurements. During the study visit, participants will answer two vision questionnaires in random order and undergo multiple eye exams and tests to assess their visual function and symptoms. Researchers will track outcomes such as low contrast defocus curve, halometry, and patient questionnaire results. Secondary measures include best corrected distance visual acuity, contrast sensitivity, pupil size, and evaluation for posterior capsular opacification or need for YAG capsulotomy. The study begins in September 2025 and will continue through August 2026.
CONDITIONS
Brief Title
Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Minimum 22 years of age
- Bilateral pseudophakia, at least 3 months after intraocular lens implantation with one of the study IOL models in at least one eye
- Willingness and cognitive ability to comply with examination procedures
- Signed informed consent and HIPAA authorization or equivalent privacy documentation
- Ability to understand and respond to questionnaires in English
You will not qualify if you...
- Clinically significant pupil abnormalities such as non-reactive, fixed, or abnormally shaped pupils
- Inability to focus or fixate for long periods (e.g., due to strabismus or nystagmus)
- Uncorrected distance visual acuity worse than 20/25 in either eye
- Prior corneal refractive surgery or intraocular surgery (except minor procedures deemed acceptable by the investigator)
- Posterior capsular opacification worse than grade 1+
- Eye conditions that may affect vision or contrast sensitivity as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a series of visual tests and complete questionnaires to evaluate low contrast visual performance, photic phenomena, and dysphotopsia profiles with various intraocular lens implants.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Empire Eye and Laser Center
Bakersfield, California, United States, 93309
Actively Recruiting
Research Team
B
Brittany M Camirand
D
Daniel H Chang, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here